Subscribe

Enlitic, Inc. (ENL.AX)

AUD0.01 +0.00 (+0.00%)
US ASX Healthcare Medical - Healthcare Information Services
Address 2510 East Harmony Road 80528
Fort Collins, CO, US
CEO Michael Karlgerhard Sistenich
IPO 2023-12-18
ISIN AU0000305427

Explore sections of this company profile

Description

Enlitic, Inc., headquartered in Fort Collins, Colorado, is a company operating in the healthcare sector across the United States, Europe, and Japan. Specializing in artificial intelligence (AI), Enlitic develops sophisticated software solutions engineered to manage and optimize medical imaging data within radiology, covering modalities such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and ultrasound. The company licenses these AI-powered solutions to both healthcare providers and original equipment manufacturers (OEMs). Its comprehensive suite of healthcare data solutions includes ENDEX, an AI platform designed to standardize diverse medical imaging data; ENCOG, an AI-enabled solution for data anonymization that effectively safeguards protected health information (PHI) while preserving crucial clinical insights in imaging studies; and Migratek, an AI-driven data migration solution, complemented by routing services. Enlitic's offerings are specifically tailored to support healthcare IT departments, hospital executives, and clinical researchers. Incorporated in 2014, the company was previously known as You Partners, Inc.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
AUD0.01 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
-0.48
Float Shares
667.88M
Free Float %
80.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% -14.29% -25.00% -14.29% -72.73% -66.67% -76.00% -99.29% -99.29% -99.29% -99.29%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.01
Quality scores
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +117.6%
  • EPS growth Medical - Healthcare Information Services: +43.1%
    +97.5%
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    -1,399.6%
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    -1,413.5%
  • ROIC Medical - Healthcare Information Services: +5.2%
    -364.5%
  • Share dilution Medical - Healthcare Information Services: -0.1%
    +3,884.1%
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    -0.02×
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.57) × ERP
WACC = 72% × Ke + 28% × Kd (4.2%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.01
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Ownership data is not available for this company yet.

Executive team

Top executives
EBIT / Employee
-1.7K
Shares Outstanding
833.18M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Michael Karlgerhard Sistenich Chief Executive Officer & Director 463.8K male
Dan Kozimor Chief Technology Officer 417.5K male
Darren Scotti Chief Financial Officer & Company Secretary 386.5K male
Scott Stanton Vice President of Sales Operations male
Steve Rankin Chief Strategy Officer male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits